undamentalytics Newsletter
Sign in

GE HealthCare cash flow statement

In fiscal 2025, GE HealthCare's operations generated $1.99bn of cash; it spent $482m on capital projects, leaving free cash flow of $1.50bn. It returned $64.0m in dividends and $200m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations1,6072,1342,1011,9551,9872,415
Depreciation and amortisation225228248268287309
Stock-based pay7667114125130151
Capital spending248310387401482526
Free cash flow1,3591,8241,7141,5541,5051,889
Free cash flow after stock pay1,2831,7571,6001,4291,3751,738
Dividends paid0041556464
Share buybacks——00200300

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BSX vs GEHCGEHC vs PHGGEHC vs SYKGEHC vs MDT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from GE HealthCare's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to GE HealthCare.